Open Access Open Access  Restricted Access Subscription or Fee Access

Adherence to chronic opioid therapy prescribing guidelines in a primary care clinic

Cynthia Kay, MD, MS, Erica Wozniak, MS, Sarah Koller, DO, Audrey Ye, MD, Joanne Bernstein, MD

Abstract


Objective: Characterize primary care patients prescribed opioids for chronic noncancer pain (CNCP), explore guideline-recommended opioid-monitoring practices, and investigate predictors of pain agreements.

Design: Retrospective chart review.

Setting: Primary care clinic at a tertiary academic medical center.

Patients: Adults prescribed chronic opioids (three or more monthly prescriptions within a year) for CNCP between April 1, 2014 and April 1, 2015. Patients without CNCP served as controls.

Main Outcome Measure: Patient demographics, medical diagnoses, tobacco status, provider status, documentation of guideline-recommended opioid-monitoring practices, pain agreement status, and opioid prescription. Univariate statistics were used to explore differences in patient demographics, comorbidities, and guideline-recommended opioid-monitoring practices by chronic pain and pain agreement status. Logistic regression was used to investigate predictors of agreement status.

Results: The clinic had 834 (9 percent) patients on chronic opioids, with 335 on a pain agreement. Documentation of opioid-monitoring practices was lacking. Logistic regression indicated that patients were significantly more likely to be on an agreement if they were Caucasian (adjusted odds ratio [OR] 2.17 [95% CI 1.41, 3.39]), had a baseline urine drug screen (adjusted OR 10.72 [95% CI 6.16, 19.41]), were prescribed a schedule II controlled medication (adjusted OR 11.92 [95% CI 6.93, 21.62]), and had risk assessed to some degree (adjusted OR 3.06 [95% CI 1.90, 4.96]).

Conclusions: Aside from race, most patient characteristics were not predictive of pain agreement implementation. However, controlled medication of higher schedules and the use of certain guideline-recommended practices were associated with an agreement. Studies are needed to examine whether pain agreement or guideline-adherence influence clinical outcomes.


Keywords


chronic pain, opioids, primary care

Full Text:

PDF

References


Volkow ND: American's addiction to opioids: Heroin and prescription drug abuse. Bethesda, MD: National Institute on Drug Abuse, 2014. Available at http://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2014/americas-addiction-to-opioids-heroin-prescription-drug-abuse. Accessed November 14, 2015.

Franklin G: Opioids for chronic noncancer pain: A position paper of the American academy of neurology. Neurology. 2014; 83(14): 1277-1284.

Gounder C: Who is responsible for the pain-pill epidemic? The New Yorker. 2013. http://www.newyorker.com/business/currency/who-is-responsible-for-the-pain-pill-epidemic. Accessed May 24, 2016.

American Pain Society (USA): Assessment of Pain, United States. Chicago, IL: American Pain Society, 2016. Available at http://americanpainsociety.org/uploads/education/section_2.pdf. Accessed May 24, 2016.

Mularski RA, White-Chu F, Overbay D, et al.: Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med. 2006; 21(6): 607-612.

Van Zee A: The promotion and marketing of oxycontin: Commercial triumph, public health tragedy. Am J Public Health. 2009; 99(2): 221-227.

Paulozzi LJ, Jones CM, Mack KA, et al.: Vitals signs: Overdoses of prescription opioid pain relievers—United States, 1998-2008. Atlanta, GA: Centers for Disease Control and Prevention, 2011. Available at http://www.cdc.gov/mmwr/pdf/wk/mm6043.pdf. Accessed November 14, 2015.

Centers for Disease Control and Prevention (USA): Prescription painkiller overdoses. Atlanta, GA: Centers for Disease Control and Prevention, 2013. Available at http://www.cdc.gov/vitalsigns/PrescriptionPainkillerOverdoses/index.html. Accessed November 14, 2015.

Consumer Reports: The dangers of painkillers: A special report. 2014. Available at http://www.consumerreports.org/cro/magazine/2014/09/the-dangers-of-painkillers/index.htm. Accessed November 14, 2015.

Cheatle MD, Barker C: Improving opioid prescription practices and reducing patient risk in the primary care setting. J Pain Res. 2014; 7: 301-311.

Prescription Drug Monitoring Program Training and Technical Assistance Center: Prescription drug monitoring frequently asked questions (FAQ). Available at http://www.pdmpassist.org/content/prescription-drug-monitoring-frequentlyasked-questions-faq. Accessed November 14, 2015.

Chou R, Fanciullo GJ, Fine PG, et al.: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10(2): 113-130.

Butler SF, Fernandez K, Benoit C, et al.: Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008; 9(4): 360-372.

Moore TM, Jones T, Browder JH, et al.: A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med. 2009; 10(8): 1426-1433.

Chou R, Fanciullo GJ, Fine PG, et al.: Opioids for chronic noncancer pain: Prediction and identification of aberrant drug-related behaviors: A review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009; 10(2): 131-146.

Sauver JL, Warner DO, Yawn BP, et al.: Why patients visit their doctors: Assessing the most prevalent conditions in a defined American population. Mayo Clin Proc. 2013; 88(1): 56-67.

Centers for Disease Control and Prevention (USA): National ambulatory medical care survey: 2010 summary table. Atlanta, GA: CDC. Available at http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_namcs_web_tables.pdf. Accessed November 14, 2015.

National Institutes of Health Medline Plus (USA): Chronic pain: Symptoms, diagnosis, & treatment. Bethesda, MD: NIH, 2011. Available at https://www.nlm.nih.gov/medlineplus/magazine/issues/spring11/articles/spring11pg5-6.html. Accessed January 10, 2016.

Elliott AM, Smith BH, Penny KI, et al.: The epidemiology of chronic pain in the community. Lancet. 1999; 354(9186): 1248-1252.

Chou R, Turner JA, Devine EB, et al.: The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015; 162(4): 276-286.

Harris PA, Taylor R, Thielke R, et al.: Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42(2): 377-381.

Fink R: Pain assessment: The cornerstone to optimal pain management. Baylor Univ Med Cent Proc. 2000; 13(3): 236.

Weimer M, Gideonse N, Mauer K, et al.: Guideline for safe chronic opioid therapy prescribing for patients with chronic non-cancer pain. 2013. Available at http://www.ohsu.edu/gim/epiclinks/opioidresources/opioidguidelines.htm#. Accessed January 12, 2016.

Von Korff M, Saunders K, Ray GT, et al.: Defacto long-term opioid therapy for non-cancer pain. Clin J Pain. 2008; 24(6): 521-527.

Morasco BJ, Duckart JP, Carr TP, et al.: Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain. 2010; 151(3): 625-632.

Beehler GP, Rodrigues AE, Mercurio-Riley D, et al.: Primary care utilization among veterans with chronic musculoskeletal pain: A retrospective chart review. Pain Med. 2013; 14(7): 1021-1031.

Krein SL, Heisler M, Piette JD, et al.: The effect of chronic pain on diabetes patients’ self-management. Diabetes Care. 2005; 28(1): 65-70.

Butchart A, Kerr EA, Heisler M, et al.: Experience and management of chronic pain among patients with other complex chronic conditions. Clin J Pain. 2009; 25(4): 293-298.

Härter M, Baumeister H, Reuter K, et al.: Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom. 2007; 76(6): 354-360.

McWilliams LA, Cox BJ, Enns MW: Mood and anxiety disorders associated with chronic pain: An examination in a nationally representative sample. Pain. 2003; 106(1): 127-133.

Gureje O, Von Korff M, Simon GE, et al.: Persistent pain and well-being: A World Health Organization study in primary care. JAMA. 1998; 280(2): 147-151.

Jiang W, Glassman A, Krishnan R, et al.: Depression and ischemic heart disease: What have we learned so far and what must we do in the future? Am Heart J. 2005; 150(1): 54-78.

Barth J, Schumacher M, Herrmann-Lingen C: Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom Med. 2004; 66(6): 802-813.

American Heart Association (USA): Mental health and heart health. 2014. Available at http://www.heart.org/HEARTORG/GettingHealthy/StressManagement/HowDoesStressAffectYou/Mental-Health-and-Heart-Health_UCM_438853_Article.jsp#. Accessed December 29, 2015.

Regier DA, Farmer ME, Rae DS, et al.: Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. JAMA. 1990; 264(19): 2511-2518.

Kessler RC, Nelson CB, McGonagle KA, et al.: The epidemiology of co-occurring addictive and mental disorders:

Implications for prevention and service utilization. Am J Orthopsychiatry. 1996; 66(1): 17-31.

Grant BF, Stinson FS, Dawson DA, et al.: Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004; 61(8): 807-816.

Ives TJ, Chelminski PR, Hammett-Stabler CA, et al.: Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res. 2006; 6(1): 46.

Turk DC, Swanson KS, Gatchel RJ: Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. Clin J Pain. 2008; 24(6): 497-508.

Krebs EE, Ramsey DC, Miloshoff JM, et al.: Primary care monitoring of long-term opioid therapy among veterans with chronic pain. Pain Med. 2011; 12(5): 740-746.

Pahuja D, Chadha P: Red flags within documentation for hospitalists. The Hospitalist. 2011. Available at http://www.the-hospitalist.org/article/red-flags-within-documentation-forhospitalists/?singlepage=1. Accessed December 18, 2015.

Wood DL: Documentation guidelines: Evolution, future direction, and compliance. Am J Med. 2001; 110(4): 332-334.

Gottschalk A, Flocke SA: Time spent in face-to-face patient care and work outside the examination room. Ann Family Med. 2005; 3(6): 488-493.

Chen MA, Hollenberg JP, Michelen W, et al.: Patient care outside of office visits: A primary care physician time study. J Gen Intern Med. 2011; 26(1): 58-63.

Tai-Seale M, McGuire TG, Zhang W: Time allocation in primary care office visits. Health Serv Res. 2007; 42(5): 1871-1894.

Chen LM, Farwell WR, Jha AK: Primary care visit duration and quality: Does good care take longer? Arch Intern Med. 2009; 169(20): 1866-1872.

Mechanic D, McAlpine DD, Rosenthal M: Are patients' office visits with physicians getting shorter? N Engl J Med. 2001; 344(3): 198-204.

Linzer M, Konrad TR, Douglas J, et al.: Managed care, time pressure, and physician job satisfaction: Results from the physician worklife study. J Gen Intern Med. 2000; 15(7): 441-450.

Gourlay DL, Heit HA, Almahrezi A: Universal precautions in pain medicine: A rational approach to the treatment of chronic pain. Pain Med. 2005; 6(2): 107-112.

Hwang CS, Turner LW, Kruszewski SP, et al.: Primary Care physicians' knowledge and attitudes regarding prescription opioid abuse and diversion. Clin J Pain. 2016; 32(4): 279-284.

Quill TE: Partnerships in patient care: A contractual approach. Ann Intern Med. 1983; 98(2): 228-234.

Fishman SM, Bandman TB, Edwards A, et al.: The opioid contract in the management of chronic pain. J Pain Symptom Manage. 1999; 18(1): 27-37.

Payne R, Anderson E, Arnold R, et al.: A rose by any other name: Pain contracts/agreements. Am J Bioeth. 2010; 10(11): 5-12.

Starrels JL, Wu B, Peyser D, et al.: It made my life a little easier: Primary care providers’ beliefs and attitudes about using opioid treatment agreements. J Opioid Manag. 2014; 10(2): 95-102.

Fagan MJ, Chen JT, Diaz JA, et al.: Do internal medicine residents find pain medication agreements useful? Clin J Pain. 2008; 24(1): 35-38.

Wiedemer NL, Harden PS, Arndt IO, et al.: The opioid renewal clinic: A primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med. 2007; 8(7): 573-584.

United States Drug Enforcement Administration: Drug scheduling. Available at http://www.dea.gov/druginfo/ds.shtml. Accessed November 14, 2015.

Bohnert AS, Valenstein M, Bair MJ, et al.: Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011; 305(13): 1315-1321.

Gomes T, Mamdani MM, Dhalla IA, et al.: Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011; 171(7): 686-691.

Dunn KM, Saunders KW, Rutter CM, et al.: Opioid prescriptions for chronic pain and overdose: A cohort study. Ann Intern Med. 2010; 152(2): 85-92.

Dowell D, Haegerich T, Chou R: CDC Guideline for prescribing opioids for chronic pain—United States, 2016. Atlanta, GA: Centers for Disease Control and Prevention, 2016. Available at http://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm#B1_down. Accessed May 23, 2016.

U.S. Food and Drug Administration: FDA News release. United States: FDA. 2013. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm367726.htm. Accessed May 24, 2016.

U.S. Food and Drug Administration: Questions and answers: FDA. Silver Spring, MD: FDA, 2013. Available at http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm309742.htm. Accessed May 24, 2016.

Starrels JL, Becker WC, Alford DP, et al.: Systematic review: Treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010; 152(11): 712-720.




DOI: https://doi.org/10.5055/jom.2016.0350

Refbacks

  • There are currently no refbacks.